Hematología
Servicio
María Eva
Mingot-Castellano
Publicaciones en las que colabora con María Eva Mingot-Castellano (16)
2024
-
ADAMTS13 recovery in acute thrombotic thrombocytopenic purpura after caplacizumab therapy
Blood, Vol. 143, Núm. 18, pp. 1807-1815
-
Avatrombopag in immune thrombocytopenia: A real-world study of the Spanish ITP Group (GEPTI)
American Journal of Hematology
2023
-
Immune thrombotic thrombocytopenic purpura in older patients: Results from the Spanish TTP Registry (REPTT)
British Journal of Haematology, Vol. 203, Núm. 5, pp. 860-871
-
Recommendations for the Clinical Approach to Immune Thrombocytopenia: Spanish ITP Working Group (GEPTI)
Journal of Clinical Medicine, Vol. 12, Núm. 20
-
Spanish registry of thrombotic thrombocytopenic purpura (REPTT): Data evidence and new developments
Transfusion and Apheresis Science, Vol. 62, Núm. 3
2022
-
Pharmacokinetic and clinical improvements after PK-guided switch from standard half-life to extended half-life factor VIII products
Thrombosis Research, Vol. 216, pp. 35-42
-
Real-world effectiveness of caplacizumab vs the standard of care in immune thrombotic thrombocytopenic purpura
Blood Advances, Vol. 6, Núm. 24, pp. 6219-6227
-
Recommendations for the diagnosis and treatment of patients with thrombotic thrombocytopenic purpura
Medicina Clinica, Vol. 158, Núm. 12, pp. 630.e1-630.e14
2021
-
Management of acquired hemophilia A: results from the Spanish registry
Blood Advances, Vol. 5, Núm. 19, pp. 3821-3829
-
Type 2N VWD: Conclusions from the Spanish PCM-EVW-ES project
Haemophilia, Vol. 27, Núm. 6, pp. 1007-1021
2020
-
Adherence to prophylaxis in adult patients with severe haemophilia A
Haemophilia, Vol. 26, Núm. 5, pp. 800-808
-
Prophylaxis therapy with bypassing agents in patients with haemophilia A and inhibitors undergoing surgery: A cost analysis in Spain
European Journal of Haematology, Vol. 105, Núm. 1, pp. 94-100
2019
2016
-
Spanish consensus guidelines on prophylaxis with bypassing agents for surgery in patients with haemophilia and inhibitors
European Journal of Haematology, Vol. 96, Núm. 5, pp. 461-474
-
Spanish consensus guidelines on prophylaxis with bypassing agents in patients with haemophilia and inhibitors
Thrombosis and Haemostasis, Vol. 115, Núm. 5, pp. 872-895
2015
-
Successful discontinuation of eltrombopag after complete remission in patients with primary immune thrombocytopenia
American Journal of Hematology, Vol. 90, Núm. 3, pp. E40-E43